89 related articles for article (PubMed ID: 22100287)
1. Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) era.
Nacci F; Matucci-Cerinic M
Best Pract Res Clin Rheumatol; 2011 Jun; 25(3):375-88. PubMed ID: 22100287
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
[TBL] [Abstract][Full Text] [Related]
3. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.
Theis VS; Rhodes JM
Aliment Pharmacol Ther; 2008 Jan; 27(1):19-30. PubMed ID: 17944997
[TBL] [Abstract][Full Text] [Related]
4. Novel screening tools for latent tuberculosis: time to leave an old friend?
Villiger PM; Zellweger JP; Möller B
Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
[TBL] [Abstract][Full Text] [Related]
5. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
[TBL] [Abstract][Full Text] [Related]
6. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
7. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
Diel R; Hauer B; Loddenkemper R; Manger B; Krüger K
Pneumologie; 2009 Jun; 63(6):329-34. PubMed ID: 19517358
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations for the diagnosis and treatment of latent and active tuberculosis in patients with inflammatory joint diseases treated with tumour necrosis factor alpha inhibitors].
Fonseca JE; Lucas H; Canhão H; Duarte R; Santos MJ; Villar M; Faustino A; Raymundo E; ;
Acta Reumatol Port; 2006; 31(3):237-45. PubMed ID: 17094335
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostics of latent tuberculosis (TB) in adult vaccinated patients (BCG) in Croatia before introduction of tumor necrosis factor antagonist therapy].
Popović-Grle S; Babić-Naglić D
Reumatizam; 2008; 55(1):31-5. PubMed ID: 19024268
[TBL] [Abstract][Full Text] [Related]
10. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
11. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
[TBL] [Abstract][Full Text] [Related]
12. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
Matulis G; Jüni P; Villiger PM; Gadola SD
Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
[TBL] [Abstract][Full Text] [Related]
13. [Tuberculosis associated with anti-TNF therapy].
Takeno M; Murakami S; Ishigatsubo Y
Nihon Rinsho; 2007 Jul; 65(7):1308-13. PubMed ID: 17642248
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis among patients treated with TNF-alpha blockers].
Fuchs-Polychuck I; Avnon LS; Abu-Shakra M
Harefuah; 2007 Mar; 146(3):212-8, 245. PubMed ID: 17460930
[TBL] [Abstract][Full Text] [Related]
15. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
Winthrop KL
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
[TBL] [Abstract][Full Text] [Related]
16. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
[TBL] [Abstract][Full Text] [Related]
17. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature.
Domm S; Cinatl J; Mrowietz U
Br J Dermatol; 2008 Dec; 159(6):1217-28. PubMed ID: 18945310
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha blockade and tuberculosis: better look before you leap.
Arend SM; Breedveld FC; van Dissel JT
Neth J Med; 2003 Apr; 61(4):111-9. PubMed ID: 12852719
[TBL] [Abstract][Full Text] [Related]
19. [Tuberculosis in the 21st century].
Yossepowitch O; Dan M
Harefuah; 2007 Mar; 146(3):206-11, 245. PubMed ID: 17460929
[TBL] [Abstract][Full Text] [Related]
20. Latent infection and tuberculosis disease in rheumatoid arthritis patients.
Acevedo-Vásquez E; Ponce de León D; Gamboa-Cárdenas R
Rheum Dis Clin North Am; 2009 Feb; 35(1):163-81. PubMed ID: 19481003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
